A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

Clinical trial NCT07710196 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07710196
Sponsor: Nacuity Pharmaceuticals, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Retinitis Pigmentosa (RP)Usher Syndrome

Start date: 2026-08-01
Primary completion: 2029-02-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.